Development and Characterization of a Wee1 Kinase Degrader

Volume: 27, Issue: 1, Pages: 57 - 65.e9
Published: Jan 1, 2020
Abstract
The G1/S cell cycle checkpoint is frequently dysregulated in cancer, leaving cancer cells reliant on a functional G2/M checkpoint to prevent excessive DNA damage. Wee1 regulates the G2/M checkpoint by phosphorylating CDK1 at Tyr15 to prevent mitotic entry. Previous drug development efforts targeting Wee1 resulted in the clinical-grade inhibitor, AZD1775. However, AZD1775 is burdened by dose-limiting adverse events, and has off-target PLK1...
Paper Details
Title
Development and Characterization of a Wee1 Kinase Degrader
Published Date
Jan 1, 2020
Volume
27
Issue
1
Pages
57 - 65.e9
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.